These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 11837383)

  • 1. Moexipril shows a long duration of action related to an extended pharmacokinetic half-life and prolonged ACE inhibition.
    Cawello W; Boekens H; Waitzinger J; Miller U
    Int J Clin Pharmacol Ther; 2002 Jan; 40(1):9-17. PubMed ID: 11837383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological and toxicological studies of the new angiotensin converting enzyme inhibitor moexipril hydrochloride.
    Friehe H; Ney P
    Arzneimittelforschung; 1997 Feb; 47(2):132-44. PubMed ID: 9079232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of a pharmacokinetic interaction between moexipril and hydrochlorothiazide.
    Hutt V; Michaelis K; Verbesselt R; De Schepper PJ; Salomon P; Bonn R; Cawello W; Angehrn JC
    Eur J Clin Pharmacol; 1996; 51(3-4):339-44. PubMed ID: 9010710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moexipril, a new angiotensin-converting enzyme (ACE) inhibitor: pharmacological characterization and comparison with enalapril.
    Edling O; Bao G; Feelisch M; Unger T; Gohlke P
    J Pharmacol Exp Ther; 1995 Nov; 275(2):854-63. PubMed ID: 7473177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pharmacodynamic and pharmacokinetic comparison of intravenous quinaprilat and oral quinapril.
    Breslin E; Posvar E; Neub M; Trenk D; Jahnchen E
    J Clin Pharmacol; 1996 May; 36(5):414-21. PubMed ID: 8739020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose responses and pharmacokinetics for the angiotensin converting enzyme inhibitor quinapril.
    Elliott HL; Macdonald NJ; Meredith PA; Reid JL
    Clin Pharmacol Ther; 1992 Mar; 51(3):260-5. PubMed ID: 1312002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of the active metabolite of benazepril, benazeprilat, and inhibition of plasma angiotensin-converting enzyme activity after single and repeated administrations to dogs.
    King JN; Mauron C; Kaiser G
    Am J Vet Res; 1995 Dec; 56(12):1620-8. PubMed ID: 8599524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of zofenopril in healthy volunteers.
    Marzo A; Dal Bo L; Mazzucchelli P; Monti NC; Tettamanti RA; Crivelli F; Uhr MR; Ismaili S; Giusti A
    Arzneimittelforschung; 1999 Dec; 49(12):992-6. PubMed ID: 10635443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of moexipril and moexiprilat, its active metabolite, in human plasma by gas chromatography-negative-ion chemical ionization mass spectrometry.
    Hammes W; Hammes B; Büchsler U; Paar F; Bökens H
    J Chromatogr B Biomed Appl; 1995 Aug; 670(1):81-9. PubMed ID: 7493088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of quinapril on angiotensin converting enzyme and plasma renin activity as well as pharmacokinetic parameters of quinapril and its active metabolite, quinaprilat, after intravenous and oral administration to mature horses.
    Davis JL; Kruger K; LaFevers DH; Barlow BM; Schirmer JM; Breuhaus BA
    Equine Vet J; 2014 Nov; 46(6):729-33. PubMed ID: 24175935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and biochemical efficacy of idrapril calcium, a novel ACE inhibitor, after multiple oral administration in humans.
    Wyld PJ; Grant J; Lippi A; Criscuoli M; Del Re G; Subissi A
    Br J Clin Pharmacol; 1994 Nov; 38(5):421-5. PubMed ID: 7893583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of the angiotensin-converting-enzyme inhibitor, benazepril, and its active metabolite, benazeprilat, in dog.
    King JN; Maurer M; Morrison CA; Mauron C; Kaiser G
    Xenobiotica; 1997 Aug; 27(8):819-29. PubMed ID: 9293618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of quinaprilat after low dose quinapril in patients with terminal renal failure.
    Wolter K; Fritschka E
    Eur J Clin Pharmacol; 1993; 44 Suppl 1():S53-6. PubMed ID: 8387427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single dose and steady state pharmacokinetics and pharmacodynamics of the ACE-inhibitor imidapril in hypertensive patients.
    Harder S; Thürmann PA; Ungethüm W
    Br J Clin Pharmacol; 1998 Apr; 45(4):377-80. PubMed ID: 9578185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.
    Squire IB; Macfadyen RJ; Lees KR; Hillis WS; Reid JL
    Br J Clin Pharmacol; 1994 Aug; 38(2):117-23. PubMed ID: 7981011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma angiotensin converting enzyme activity and pharmacokinetics of benazepril and benazeprilat in cats after single and repeated oral administration of benazepril.HCl.
    King JN; Humbert-Droz E; Maurer M
    J Vet Pharmacol Ther; 1999 Dec; 22(6):360-7. PubMed ID: 10651464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moexipril does not alter the pharmacokinetics or pharmacodynamics of warfarin.
    Van Hecken A; Verbesselt R; Depré M; Tjandramaga TB; Angehrn J; Cawello W; De Schepper PJ
    Eur J Clin Pharmacol; 1993; 45(3):291-3. PubMed ID: 8276058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tricenter assessment of the efficacy of the ACE inhibitor, moexipril, by ambulatory blood pressure monitoring.
    White WB; Whelton A; Fox AA; Stimpel M; Kaihlanen PM
    J Clin Pharmacol; 1995 Mar; 35(3):233-8. PubMed ID: 7608310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic alterations of quinapril during repeated treatment in elderly subjects.
    Sasaki M; Maeda A; Fujimura A
    Eur J Clin Pharmacol; 1998 Jun; 54(4):347-9. PubMed ID: 9696962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.